PillFondaparinux Sodium
Fondaparinux Sodium
2 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Sandoz Inc | unknown | 8 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 8 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Sep 29, 2025RESOLVEDShortage resolved: Fondaparinux Sodium Injection (Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.))
Fondaparinux Sodium Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.). Therapeutic category: Hematology.
- Sep 29, 2025SHORTAGEDrug shortage: Fondaparinux Sodium Injection (Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.))
Fondaparinux Sodium Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.). Therapeutic category: Hematology.